ViewRay (VRAYQ) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock VRAYQ vs. SDCCQ, GMVDF, AFIB, SONX, NMRD, UTRS, MOTS, VIVE, DRTSW, and ANZUWShould you be buying ViewRay stock or one of its competitors? The main competitors of ViewRay include SmileDirectClub (SDCCQ), G Medical Innovations (GMVDF), Acutus Medical (AFIB), Sonendo (SONX), Nemaura Medical (NMRD), Minerva Surgical (UTRS), Motus GI (MOTS), Viveve Medical (VIVE), Alpha Tau Medical (DRTSW), and Anzu Special Acquisition Corp I (ANZUW). These companies are all part of the "medical equipment" industry. ViewRay vs. Its Competitors SmileDirectClub G Medical Innovations Acutus Medical Sonendo Nemaura Medical Minerva Surgical Motus GI Viveve Medical Alpha Tau Medical Anzu Special Acquisition Corp I ViewRay (NASDAQ:VRAYQ) and SmileDirectClub (NASDAQ:SDCCQ) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, media sentiment, profitability, dividends, valuation, institutional ownership and earnings. Is VRAYQ or SDCCQ more profitable? Company Net Margins Return on Equity Return on Assets ViewRayN/A N/A N/A SmileDirectClub N/A N/A N/A Do insiders and institutionals believe in VRAYQ or SDCCQ? 15.5% of ViewRay shares are held by institutional investors. Comparatively, 0.1% of SmileDirectClub shares are held by institutional investors. 2.5% of ViewRay shares are held by insiders. Comparatively, 64.7% of SmileDirectClub shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has more volatility and risk, VRAYQ or SDCCQ? ViewRay has a beta of 1.05, suggesting that its stock price is 5% more volatile than the S&P 500. Comparatively, SmileDirectClub has a beta of 1.47, suggesting that its stock price is 47% more volatile than the S&P 500. Which has higher earnings & valuation, VRAYQ or SDCCQ? SmileDirectClub has higher revenue and earnings than ViewRay. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioViewRay$102.21M0.00-$107.33MN/AN/ASmileDirectClub$470.74M0.00-$86.40MN/AN/A Does the media prefer VRAYQ or SDCCQ? In the previous week, ViewRay's average media sentiment score of 0.00 equaled SmileDirectClub'saverage media sentiment score. Company Overall Sentiment ViewRay Neutral SmileDirectClub Neutral SummarySmileDirectClub beats ViewRay on 4 of the 5 factors compared between the two stocks. Get ViewRay News Delivered to You Automatically Sign up to receive the latest news and ratings for VRAYQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VRAYQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VRAYQ vs. The Competition Export to ExcelMetricViewRayElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$18K$34.08M$5.61B$9.84BDividend YieldN/AN/A4.61%4.07%P/E RatioN/A2.8630.2825.74Price / SalesN/A208.64460.47115.79Price / CashN/A41.3638.2159.48Price / BookN/A2.148.856.15Net Income-$107.33M-$2.66M$3.25B$265.06M ViewRay Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VRAYQViewRayN/AN/AN/AN/A$18K$102.21M0.00300High Trading VolumeSDCCQSmileDirectClubN/AN/AN/AN/A$40K$470.74M0.002,700Gap DownGMVDFG Medical InnovationsN/AN/AN/AN/A$26K$4.42M0.0072AFIBAcutus MedicalN/A$0.00flatN/A-98.2%$15K$7.16M0.00340SONXSonendo0.8908 of 5 stars$0.02flatN/AN/A$9K$44.40M0.00250Short Interest ↓NMRDNemaura Medical1.2155 of 5 starsN/AN/AN/A$4K$3.02K0.0040UTRSMinerva SurgicalN/A$0.00flatN/AN/A$1K$51.69M0.00160MOTSMotus GI0.1359 of 5 stars$0.00flatN/AN/A$1K$319K0.0030VIVEViveve MedicalN/A$0.00flatN/A-66.7%$1K$6.83M0.0070DRTSWAlpha Tau MedicalN/A$0.27-0.4%N/A+48.3%$0.00N/A0.0080News CoverageANZUWAnzu Special Acquisition Corp IN/A$0.05+3.5%N/A-42.1%$0.00N/A0.002Gap Up Related Companies and Tools Related Companies SmileDirectClub Alternatives G Medical Innovations Alternatives Acutus Medical Alternatives Sonendo Alternatives Nemaura Medical Alternatives Minerva Surgical Alternatives Motus GI Alternatives Viveve Medical Alternatives Alpha Tau Medical Alternatives Anzu Special Acquisition Corp I Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VRAYQ) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ViewRay, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ViewRay With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access